Stock screenerAll disclosures →
EDGAR →
SDEV
Conviction 0HealthcareScan · Thu, Jun 25, 2026SDEV$1.14+2.70%
ResistanceSupportVol 14Insider buyInsider sellVol MA14 299.83K
Apr 6Apr 21May 6May 22Jun 9Jun 25
Price1.14
Change+2.70%
Gap+3.60%
Rel volume0.93×
Avg volume263.42K
Avg $ vol296.02K
SMA 201.15
SMA 501.34
SMA 200—
Price vs 50-14.91%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 1.45
RSI (14)43
MACD hist0.02
MACD crossbull · 5d
Stoch %K / %D27 / 26
ADX (14)23
+DI / −DI19 / 17
RSI divergenceBullish
MACD divergence—
ATR %+11.84%
ADR %10.32%
52w high1.88
52w low1.01
From 52w high-39.36%
Above 52w low+12.87%
New 52w highNo
SqueezeOn · 2d
Bollinger width25.22%
%B0.48
Donchian pos27.27%
Donchian high1.50
Donchian low1.01
AVWAP (52w high)1.38
vs AVWAP high-17.33%
AVWAP (52w low)1.15
vs AVWAP low-0.62%
OBV trendUp
Chaikin MF (20)-0.26
Today vs 20d0.93×
Avg vol (14d)299.83K
Avg vol (20d)263.42K
Avg $ vol (20d)296.02K
Market cap30.91M
RS 3m (vs SPY)—
RS 6m (vs SPY)—
RS line new highNo
Trend template—
Technical rank19.5
1 week-4.20%
1 month-12.98%
3 months—
6 months—
1 year—
YTD-39.36%
P/E-1.40
P/B0.22
P/S83.55
P/FCF-3.66
EPS-0.3100
Div yield15.53%
ROE-15.95%
ROA-12.32%
Debt/Eq0.00
Current5.33
EV/EBITDA-1.50
Gross margin—
Net margin—
Rev growth-88.63%
EPS growth-206.53%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value12.61M
Revenue46K
Net income552.4M
Gross profit42K
Free cash flow-8.44M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out27.12M
Employees4
ListedWed, Apr 26, 2000
Free float2.96M
Float %10.9%
Short interest293.89K
Days to cover0.4d
Short volume47.7%
Squeeze score27 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank19.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.77
Support1.04
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SDEV
No recent disclosed trades by Congress in SDEV. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SDEV · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Framework Ventures IV L.P. 10% owner · Common Stock · 2026-06-15 | Exercise | 11.33M | $27K | 2026-06-15 | 2026-06-17 |
Framework Ventures IV L.P. 10% owner · Common Stock · 2026-06-15 | Sell | 24.72K | $27K | 2026-06-15 | 2026-06-17 |
Framework Ventures IV L.P. 10% owner · Pre-Funded Warrants (Right to Buy) · 2026-06-15 | Exercise | 11.33M | — | 2026-06-15 | 2026-06-17 |
R01 Fund LP 10% owner · Pre-Funded Warrants (Right to Buy) · 2026-01-16 | Buy | 53.68M | $46M | 2026-01-16 | 2026-05-19 |
Anderson Michael Ernest 10% owner · Pre-Funded Warrants (Right to Buy) · 2026-01-16 | Buy | 50.11M | $43M | 2026-01-16 | 2026-05-19 |
Framework Ventures IV L.P. 10% owner · Pre-Funded Warrants (Right to Buy) · 2026-01-16 | Buy | 50.11M | $43M | 2026-01-16 | 2026-05-19 |
R01 Capital Manager LLC 10% owner · Pre-Funded Warrants (Right to Buy) · 2026-01-16 | Buy | 53.68M | $46M | 2026-01-16 | 2026-05-19 |
Kazley Michael John Chief Executive Officer · Pre-Funded Warrants (Right to Buy) · 2026-01-16 | Buy | 53.68M | $46M | 2026-01-16 | 2026-05-19 |
Kazley Michael John Chief Executive Officer · Pre-Funded Warrants (Right to Buy) · 2026-01-16 | Buy | 53.68M | $46M | 2026-01-16 | 2026-05-19 |
Framework Ventures IV GP LLC 10% owner · Pre-Funded Warrants (Right to Buy) · 2026-01-16 | Buy | 50.11M | $43M | 2026-01-16 | 2026-05-19 |
SEC filings
EDGAR filings in SDEV · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.